Caroline Loewy
Directeur/Membre du Conseil chez EFFECTOR THERAPEUTICS, INC.
Fortune : 8 871 $ au 30/04/2024
Postes actifs de Caroline Loewy
Sociétés | Poste | Début | Fin |
---|---|---|---|
EFFECTOR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/09/2023 | - |
Global Genes
Global Genes Miscellaneous Commercial ServicesCommercial Services Global Genes is a non-profit organization that connects, empowers, and inspires the rare disease community to become more effective on their own behalf. The non-profit company is based in Aliso Viejo, CA and has subsidiaries in the United States. The company serve more than 400 million people around the globe and nearly one in 10 Americans affected by rare diseases. The organization helps spur innovation, meet essential needs, build capacity and knowledge, and drive progress within and across rare diseases. Global Genes was founded in 2008 and the CEO is Craig Martin. | Directeur/Membre du Conseil | 01/06/2009 | - |
Kcnq2 Cure Alliance, Inc. | Directeur/Membre du Conseil | 01/10/2014 | - |
Historique de carrière de Caroline Loewy
Anciens postes connus de Caroline Loewy
Sociétés | Poste | Début | Fin |
---|---|---|---|
CYMABAY THERAPEUTICS, INC. | Directeur/Membre du Conseil | 06/12/2016 | 22/03/2024 |
Independent Dir/Board Member | 06/12/2016 | 22/03/2024 | |
PHASEBIO PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 19/07/2018 | 27/09/2023 |
Independent Dir/Board Member | 19/07/2018 | 27/09/2023 | |
APTOSE BIOSCIENCES INC. | Directeur/Membre du Conseil | 25/04/2018 | 31/05/2022 |
Independent Dir/Board Member | - | 31/05/2022 | |
ZOGENIX, INC. | Directeur/Membre du Conseil | 21/09/2020 | 07/03/2022 |
Independent Dir/Board Member | 21/09/2020 | 07/03/2022 | |
EFFECTOR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2021 | 01/08/2021 |
Independent Dir/Board Member | 01/01/2021 | 01/08/2021 | |
ACHIEVE LIFE SCIENCES, INC. | Directeur Financier/CFO | 12/05/2015 | 01/08/2017 |
Fondateur | 01/10/1991 | 01/08/2017 | |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░ ░ ░░░ ░░░ | ░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formation de Caroline Loewy
Carnegie Mellon University | Graduate Degree |
University of California, Berkeley | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 16 |
Canada | 3 |
Opérationnelle
Director/Board Member | 9 |
Independent Dir/Board Member | 6 |
Director of Finance/CFO | 4 |
Sectorielle
Health Technology | 10 |
Finance | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 6 |
---|---|
PONIARD PHARMACEUTICALS, INC. | Health Technology |
APTOSE BIOSCIENCES INC. | Health Technology |
CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
ACHIEVE LIFE SCIENCES, INC. | Health Technology |
EFFECTOR THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 9 |
---|---|
Prudential Securities | Finance |
CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Zogenix, Inc.
Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Finance |
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Kcnq2 Cure Alliance, Inc. | |
Global Genes
Global Genes Miscellaneous Commercial ServicesCommercial Services Global Genes is a non-profit organization that connects, empowers, and inspires the rare disease community to become more effective on their own behalf. The non-profit company is based in Aliso Viejo, CA and has subsidiaries in the United States. The company serve more than 400 million people around the globe and nearly one in 10 Americans affected by rare diseases. The organization helps spur innovation, meet essential needs, build capacity and knowledge, and drive progress within and across rare diseases. Global Genes was founded in 2008 and the CEO is Craig Martin. | Commercial Services |
Locust Walk Acquisition Corp.
Locust Walk Acquisition Corp. Financial ConglomeratesFinance Locust Walk Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 2, 2020 and is headquartered in Boston, MA. | Finance |
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. Financial ConglomeratesFinance Phoenix Biotech Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on June 8, 2021 and is headquartered in Oakland, CA. | Finance |
- Bourse
- Insiders
- Caroline Loewy
- Expérience